Could a common drug ease chronic stomach pain and nausea?

NCT ID NCT01696734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether domperidone, a drug that helps the stomach empty food, can reduce symptoms like pain, bloating, nausea, and vomiting in people with chronic digestive disorders. About 200 patients who have not improved with standard treatments will take domperidone and report their symptom changes over 8 weeks. The goal is to see if the drug can provide relief for conditions such as gastroparesis, severe heartburn, and indigestion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Domperidone
What this could lead to
If it works, this could provide a treatment option for people with chronic gastrointestinal disorders who have not been helped by standard therapies.
What could go wrong
This is an early-phase trial with only 200 participants, and it focuses on symptom improvement rather than a cure. Domperidone may cause side effects, and its long-term safety is not fully established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGESTIVE SYSTEM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.